Question 1

What is the analyst consensus rating for CSTL?

Accepted Answer

The analyst consensus rating for CSTL is "Buy" based on 4 analyst recommendations.

Question 2

What is the average price target for CSTL?

Accepted Answer

The average 12-month price target for CSTL is $49.75, representing an upside of 49.3% from the current price of $33.32.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Jan 26, 2026	Subbu Nambi	Guggenheim	Maintains	Strong Buy	$43.00 → $47.00 +4.00 (9.3%)
Jan 12, 2026	Thomas Flaten	Lake Street	Maintains	Strong Buy	$35.00 → $52.00 +17.00 (48.6%)
Jan 5, 2026	Subbu Nambi	Guggenheim	Maintains	Strong Buy	$30.00 → $43.00 +13.00 (43.3%)
Dec 22, 2025	Kyle Mikson	Canaccord Genuity	Maintains	Strong Buy	$37.00 → $50.00 +13.00 (35.1%)
Dec 12, 2025	Mark Massaro	BTIG	Maintains	Strong Buy	$38.00 → $50.00 +12.00 (31.6%)

Castle Biosciences (CSTL) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest CSTL Analyst Ratings & Recommendations